Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10933
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYuldasheva N. Z., Shukurov F. I.-
dc.date.accessioned2024-05-01T17:34:32Z-
dc.date.available2024-05-01T17:34:32Z-
dc.date.issued2024-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/10933-
dc.description.abstractAbstract The study included 120 women with menstrual-ovarian cycle disorders against the background of COVID-19. According to the clinical course of COVID-19, all patients were divided into three groups. The first group consisted of 45 women (37.5%) with a mild form of COVID-19, the second group included 43 women (35.8%) with moderate COVID-19, and the third group comprised 32 women (26.7%) with severe COVID-19. The study results demonstrate a significant impact of COVID-19 on the hemostasis state in 92% of women with menstrual-ovarian function disorders against the background of COVID-19. The levels of fibrinogen are 1.8 times and D-dimer on average 2.0 times higher than in healthy women. A correlation has been established between the levels of D-dimer, fibrinogen, and the severity of the clinical course of COVID-19, specifically, the presence of a direct correlation of these indicators with the severe form of COVID-19.en_US
dc.language.isoen_USen_US
dc.publisherPublished by Scientific & Academic Publishingen_US
dc.subjectHemostasis, Women, MenstruaL-Ovarian Cycle Disorders, COVID-19en_US
dc.titleFeatures of Hemostasis in Women with MenstruaL-Ovarian Cycle Disorders Against the Background of COVID-19en_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
Юлдашева Н.З. Америка мақоласи.pdfFeatures of Hemostasis in Women with MenstruaL-Ovarian Cycle Disorders Against the Background of COVID-19111.24 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.